Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 45

Results For "advance"

3169 News Found

Bayer’s stroke drug wins fast-track review in US
Drug Approval | May 20, 2026

Bayer’s stroke drug wins fast-track review in US

The development comes as stroke remains one of the world’s biggest health threats


MedGenome to expand integrated diagnostics access across Mumbai suburbs
Healthcare | May 19, 2026

MedGenome to expand integrated diagnostics access across Mumbai suburbs

Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets


NunaBio secures £6.5 million to scale DNA manufacturing platform
Biotech | May 19, 2026

NunaBio secures £6.5 million to scale DNA manufacturing platform

Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics


Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization
Supply Chain | May 19, 2026

Annora Pharma expands partnership with AltiusHub to strengthen AI-driven serialization

Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets


FDA expands Enhertu use in early HER2-positive breast cancer
Drug Approval | May 19, 2026

FDA expands Enhertu use in early HER2-positive breast cancer

AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease


Lupin debuts in Dow Jones best-in-class indices for ESG performance
News | May 19, 2026

Lupin debuts in Dow Jones best-in-class indices for ESG performance

The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index


Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer
Biopharma | May 19, 2026

Roche Pharma launches India’s first subcutaneous immunotherapy for lung cancer

Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs


Medix Biochemica unleashes $5 million expansion to secure future of IVD supply chain
R&D | May 19, 2026

Medix Biochemica unleashes $5 million expansion to secure future of IVD supply chain

The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030